Entering text into the input field will update the search result below

Auspex candidate for TS tagged an Orphan Drug

Jan. 14, 2015 2:06 PM ETAuspex Pharmaceuticals, Inc (ASPX) StockASPXBy: Douglas W. House, SA News Editor
  • The FDA designates Auspex Pharmaceuticals' (ASPX +2.1%) investigational compound, SD-809, an Orphan Drug for the treatment of pediatric patients with Tourette syndrome. The product is currently in Phase 1b development.
  • Among the benefits of Orphan Drug status is a seven-year period of market exclusivity if approved.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ASPX--
Auspex Pharmaceuticals, Inc
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.